Aunque GLP-1 es conocido por su efecto incretnico, que comparte con el pptido insulinotrpico dependiente de la glucosa (GIP), la accin reguladora de la ingesta, esencial para su eficacia frente a la obesidad, tiene lugar merced a su interaccin con receptores localizados en el SNC1,5
Mounjaro was approved by the FDA in 2022 as a GIP and GLP-1 receptor agonist for improving blood sugar control in adults with type 2 diabetes, and subsequent trials went on to evaluate its effects specifically on body weight in people with obesity or overweight
I have had a patient say that her burps smelled like poop, Davisson said
Patient's started on a lower dose and then built up gradually to reduce side effects
Before choosing between these two ED pills, it is important to understand how they compare in terms of cost, effectiveness, dosage, and safety